EX-32.1 5 tv525984_ex32-1.htm EXHIBIT 32.1

 

Exhibit 32.1

 

CERTIFICATION OF

PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT of 2002

 

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Phillip Chan, the President and Chief Executive Officer of CytoSorbents Corporation, hereby certify, that, to my knowledge:

 

1. The Quarterly Report on Form 10-Q for the quarter ending June 30, 2019 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2. The information contained in such Quarterly Report on Form 10-Q for the quarter ending June 30, 2019, fairly presents, in all material respects, the financial condition and results of operations of CytoSorbents Corporation.

 

Date:  August 6, 2019

 

CYTOSORBENTS CORPORATION

 

By: /s/ Phillip P. Chan  
Phillip Chan  
President and Chief Executive Officer